Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
7.30
-0.24 (-3.18%)
At close: Oct 7, 2025, 4:00 PM EDT
7.30
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:00 PM EDT
Biodesix Revenue
Biodesix had revenue of $20.02M in the quarter ending June 30, 2025, with 11.68% growth. This brings the company's revenue in the last twelve months to $76.56M, up 25.70% year-over-year. In the year 2024, Biodesix had annual revenue of $71.32M with 45.30% growth.
Revenue (ttm)
$76.56M
Revenue Growth
+25.70%
P/S Ratio
0.72
Revenue / Employee
$280,425
Employees
273
Market Cap
57.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 71.32M | 22.24M | 45.30% |
Dec 31, 2023 | 49.09M | 10.88M | 28.46% |
Dec 31, 2022 | 38.21M | -16.29M | -29.89% |
Dec 31, 2021 | 54.51M | 8.95M | 19.64% |
Dec 31, 2020 | 45.56M | 21.01M | 85.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BDSX News
- 1 day ago - Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit - GlobeNewsWire
- 26 days ago - Biodesix Announces One-for-Twenty Reverse Stock Split - GlobeNewsWire
- 4 weeks ago - Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference - GlobeNewsWire
- 7 weeks ago - Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewsWire
- 2 months ago - Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Biodesix Announces Second Quarter 2025 Results and Highlights - GlobeNewsWire
- 2 months ago - Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 2 months ago - Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire